Scientific American offers an article on recent research from Ohio State University that may turn out to be a biomarker that could help physicians prescribe the best antipsychotic drug for a patient with a mental illness. The research team found SNPs and other variation in the gene that codes for a receptor for dopamine, which could help explain why patients have long shown very different reactions to antipsychotic drugs.